Delivered by BioMelbourne Network and supported by the Victorian Government, this upcoming BioForum will explore how emerging technologies are reshaping the…
FIND OUT MOREPosted: 30 June 2025 Atmo Biosciences has been granted clearance by the United States Food and Drug Administration (FDA) under…
READ MOREPosted: 30 June 2025 Noxopharm Limited (ASX:NOX), a clinical-stage biotechnology firm, has announced rapid progress in the recruitment phase of…
READ MOREPosted: 25 June 2025 This article recaps BioMelbourne Network’s BioForum “Stepping off the ledge – Quantum, AI technologies and the…
READ MORE